Wave Life Sciences Ltd.

Historical 13F Holders

Symbol
WVE
CUSIP
Y95308105
All holders as of
Q2 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for Y95308105 since 12/18/2024, newest first.

Filer % of Class Filed
Adage Capital Management, L.P. 13G/A Amendment 6
0.5% 5/13/2026
Event 3/31/2026
FMR LLC 13G/A Amendment 1
2.8% 5/6/2026
Event 3/31/2026
RA Capital Management, L.P. 13D/A Amendment 10
17.1% 4/17/2026
Event 4/15/2026
RA Capital Management, L.P. 13D/A Amendment 9
17.5% 3/30/2026
Event 3/26/2026
Adage Capital Management, L.P. 13G/A Amendment 5
5.4% 2/12/2026
Event 12/31/2025
FMR LLC 13G
8.5% 2/5/2026
Event 12/31/2025
RA Capital Management, L.P. 13D/A Amendment 8
13.4% 12/15/2025
Event 12/11/2025
RA Capital Management, L.P. 13D/A Amendment 7
14.6% 11/13/2025
Event 11/11/2025
Adage Capital Management, L.P. 13G/A Amendment 4
9.7% 8/12/2025
Event 6/30/2025
Adage Capital Management, L.P. 13G/A Amendment 3
8.2% 5/12/2025
Event 3/31/2025
Maverick Capital, Ltd. 13G/A Amendment 3
5.4% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A Amendment 1 6.1% 2/5/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 322 $1.19 k
2026 Q2 253 183 M $1.20 B
2026 Q1 257 173 M $1.25 B
2025 Q4 245 183 M $3.11 B
2025 Q3 211 145 M $1.06 B
2025 Q2 187 139 M $905 M
2025 Q1 211 131 M $1.06 B
2024 Q4 198 129 M $1.59 B
2024 Q3 172 121 M $990 M
2024 Q2 154 96.4 M $481 M
2024 Q1 142 95.1 M $587 M
2023 Q4 124 93.6 M $474 M
2023 Q3 87 72.6 M $417 M
2023 Q2 85 72.2 M $263 M
2023 Q1 77 70.1 M $303 M
2022 Q4 82 68.4 M $478 M
2022 Q3 64 67.3 M $243 M
2022 Q2 63 67.8 M $220 M
2022 Q1 86 47.9 M $95.8 M
2021 Q4 102 47.4 M $149 M
2021 Q3 94 37.4 M $184 M
2021 Q2 96 37.0 M $247 M
2021 Q1 123 38.3 M $215 M
2020 Q4 127 36.1 M $284 M
2020 Q3 126 37.1 M $316 M
2020 Q2 102 29.6 M $308 M
2020 Q1 89 30.1 M $282 M
2019 Q4 117 29.8 M $239 M
2019 Q3 97 30.9 M $634 M
2019 Q2 120 30.5 M $796 M
2019 Q1 121 29.7 M $1.15 B
2018 Q4 95 24.6 M $1.03 B
2018 Q3 97 23.9 M $1.20 B
2018 Q2 80 24.6 M $940 M
2018 Q1 80 23.7 M $951 M
2017 Q4 73 22.2 M $780 M
2017 Q3 59 20.5 M $447 M
2017 Q2 56 19.3 M $359 M
2017 Q1 50 15.7 M $432 M
2016 Q4 52 14.8 M $389 M
2016 Q3 46 14.1 M $457 M
2016 Q2 39 14.2 M $294 M
2016 Q1 23 14.0 M $192 M
2015 Q4 20 13.8 M $219 M